New Covid infections appear to be surging in China due to the rise of the XBB sub-lineage of the Omicron variant.
The annual meeting of the Chinese legislature coincides with a once-in-five-years reshuffle of the cabinet, as President Xi Jinping seeks to bring the bureaucracy under his direct control.
For the better part of three years, Hong Kongers have had to wear masks just about everywhere, even after Omicron tore through the population.
The stock is already down about 15% in 2023 as the pharmaceutical giant gets set to report earnings.
If the reopening was that bullish shouldn't buyers be more aggressive?
Entering 2023, we can feel inflation easing and are watching for long-term gain from the removal of zero-Covid in China, even if it results in short-term pain.
Funny how re-openings work after forced shutdowns fail in one way or another.
We expect Chinese travelers to return in large numbers, as Asian nations slap new restrictions on arrivals from the last major nation to learn to "live with Covid."
Since 1950, the traditional 'Santa Claus rally' period has produced positive results about 78% of the time.
Let's see how willing buyers are to embrace the hope of a Santa rally.